Last reviewed · How we verify
Extended Release Tacrolimus Tablets
Extended Release Tacrolimus Tablets is a Small molecule drug developed by Roy D. Bloom, MD. It is currently FDA-approved. Also known as: LCPT, Envarsus XR®.
At a glance
| Generic name | Extended Release Tacrolimus Tablets |
|---|---|
| Also known as | LCPT, Envarsus XR® |
| Sponsor | Roy D. Bloom, MD |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants (PHASE4)
- Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen (PHASE2)
- Extended-Release Tacrolimus Following Liver Transplantation (PHASE4)
- Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation (NA)
- Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant (PHASE4)
- Early Use of Long-acting Tacrolimus in Lung Transplant Recipients (EARLY_PHASE1)
- Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation (PHASE4)
- Envarsus XR in Lung Transplant (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Extended Release Tacrolimus Tablets CI brief — competitive landscape report
- Extended Release Tacrolimus Tablets updates RSS · CI watch RSS
- Roy D. Bloom, MD portfolio CI
Frequently asked questions about Extended Release Tacrolimus Tablets
What is Extended Release Tacrolimus Tablets?
Extended Release Tacrolimus Tablets is a Small molecule drug developed by Roy D. Bloom, MD.
Who makes Extended Release Tacrolimus Tablets?
Extended Release Tacrolimus Tablets is developed and marketed by Roy D. Bloom, MD (see full Roy D. Bloom, MD pipeline at /company/roy-d-bloom-md).
Is Extended Release Tacrolimus Tablets also known as anything else?
Extended Release Tacrolimus Tablets is also known as LCPT, Envarsus XR®.
What development phase is Extended Release Tacrolimus Tablets in?
Extended Release Tacrolimus Tablets is FDA-approved (marketed).
Related
- Manufacturer: Roy D. Bloom, MD — full pipeline
- Also known as: LCPT, Envarsus XR®
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing